Cancer in Young Adults Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant
Condition: Hematopoietic Stem Cell Transplantation Intervention: Behavioral: Advance Care Planning conversations Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2022 Category: Research Source Type: clinical trials

Adolescents and Young Adults (AYAs) With Advanced Cancer
Condition: Adolescent and Young Adult Cancer Patient Interventions: Behavioral: Symptom Management for Improved Physical and Emotional Wellbeing (SMILE); Behavioral: Education Control Arm Sponsors: Duke University; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2022 Category: Research Source Type: clinical trials

Opening the Conversation: study protocol for a Phase III trial to evaluate a couple-based intervention to reduce reproductive and sexual distress among young adult breast and gynecologic cancer survivor couples
This study evaluates the efficacy of a virtual couple-based intervention called Opening the Conversation (OC). The OC intervention is grounded in theory and evidence-based practice and was adapted to improve coping and communication specifically in relation to RSH concerns after cancer.MethodsThis Phase III trial is conducted in a fully remote setting and enrolls young adult couples (current age 18 –44 years) with a history of breast or gynecologic cancer (stage 1–4, diagnosed under age 40) within the past 6 months to 5 years. Eligible dyads are recruited from across the USA. The target sample size is 100 couples. Dyad...
Source: Trials - September 2, 2022 Category: Research Source Type: clinical trials

A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Lymphoma (B-ALL)
Condition: B-cell Acute Lymphoblastic Leukemia Intervention: Biological: Tisagenlecleucel Sponsors: Memorial Sloan Kettering Cancer Center; Novartis Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 15, 2022 Category: Research Source Type: clinical trials